F. S. van Dam

1.1k total citations
8 papers, 830 citations indexed

About

F. S. van Dam is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Genetics. According to data from OpenAlex, F. S. van Dam has authored 8 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in F. S. van Dam's work include Cancer-related cognitive impairment studies (6 papers), Breast Cancer Treatment Studies (3 papers) and Brain Metastases and Treatment (3 papers). F. S. van Dam is often cited by papers focused on Cancer-related cognitive impairment studies (6 papers), Breast Cancer Treatment Studies (3 papers) and Brain Metastases and Treatment (3 papers). F. S. van Dam collaborates with scholars based in Netherlands, Canada and New Zealand. F. S. van Dam's co-authors include Tim A. Ahles, Ian F. Tannock, Patricia A. Ganz, Sabine C. Linn, Sanne B. Schagen, C. Schilder, Willem Boogerd, Chad M. Gundy, L.V.A.M. Beex and Caroline Seynaeve and has published in prestigious journals such as Journal of Clinical Oncology, NeuroImage and Psycho-Oncology.

In The Last Decade

F. S. van Dam

8 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. S. van Dam Netherlands	6	587	363	175	136	108	8	830
Helena Harder United Kingdom	17	312 0.5×	320 0.9×	244 1.4×	57 0.4×	67 0.6×	26	899
Yee Pin Tan Singapore	12	376 0.6×	190 0.5×	196 1.1×	65 0.5×	33 0.3×	22	612
Leigh Anne Faul United States	13	551 0.9×	261 0.7×	470 2.7×	103 0.8×	68 0.6×	19	981
Mihaela A. Popa United States	7	288 0.5×	182 0.5×	246 1.4×	41 0.3×	36 0.3×	13	692
Olivier Rigal France	17	683 1.2×	298 0.8×	345 2.0×	30 0.2×	15 0.1×	51	1.0k
H. Irving Pierce United States	14	162 0.3×	75 0.2×	244 1.4×	58 0.4×	33 0.3×	22	834
Kristin Härtl Germany	10	233 0.4×	67 0.2×	381 2.2×	134 1.0×	64 0.6×	23	680
Wilmy Cleijne Netherlands	6	201 0.3×	198 0.5×	81 0.5×	54 0.4×	75 0.7×	6	442
Catherine E. Jansen United States	12	729 1.2×	469 1.3×	239 1.4×	29 0.2×	14 0.1×	13	850
Lara Heflin United States	9	112 0.2×	111 0.3×	225 1.3×	38 0.3×	15 0.1×	18	619

Countries citing papers authored by F. S. van Dam

Since Specialization

Citations

This map shows the geographic impact of F. S. van Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. S. van Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. S. van Dam more than expected).

Fields of papers citing papers by F. S. van Dam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. S. van Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. S. van Dam. The network helps show where F. S. van Dam may publish in the future.

Co-authorship network of co-authors of F. S. van Dam

This figure shows the co-authorship network connecting the top 25 collaborators of F. S. van Dam. A scholar is included among the top collaborators of F. S. van Dam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. S. van Dam. F. S. van Dam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Schilder, C., Caroline Seynaeve, L.V.A.M. Beex, et al.. (2010). Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial. Journal of Clinical Oncology. 28(8). 1294–1300. 203 indexed citations

Schilder, C., Caroline Seynaeve, Sabine C. Linn, et al.. (2009). The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. Psycho-Oncology. 19(4). 415–422. 36 indexed citations

Ruiter, Michiel B. de, Liesbeth Reneman, Willem Boogerd, et al.. (2009). Cerebral Hyporesponsiveness and Cognitive Impairment Ten Years after Chemotherapy for Breast Cancer. NeuroImage. 47. S46–S46. 2 indexed citations

Schilder, C., Caroline Seynaeve, Sabine C. Linn, et al.. (2008). Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncologica. 48(1). 76–85. 95 indexed citations

Schilder, C., et al.. (2007). Neuropsychological sequelae of tamoxifen and exemestane after AC-chemotherapy in postmenopausal women with early breast cancer. Journal of Clinical Oncology. 25(18_suppl). 566–566. 2 indexed citations

Tannock, Ian F., Tim A. Ahles, Patricia A. Ganz, & F. S. van Dam. (2004). Cognitive Impairment Associated With Chemotherapy for Cancer: Report of a Workshop. Journal of Clinical Oncology. 22(11). 2233–2239. 330 indexed citations

Aaronson, N.K., Martin J. Muller, Astrid C. van der Schot, et al.. (1996). Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials.. Journal of Clinical Oncology. 14(3). 984–996. 148 indexed citations

Aaronson, Neil K., F. S. van Dam, Sophie D. Fosså, et al.. (1986). Quality of life assessment in bladder cancer clinical trials: conceptual, methodological and practical issues.. PubMed. 221. 149–70. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact